Use for dendropanax morbifera extract for adjusting 15- hydroxyprostaglandin dehydrogenase and PGE 2 activity
US9649350B2 · kind B2 · utility
6Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 28, 2014 |
| Grant date | May 16, 2017 |
| Priority date | — |
| Expiry date | Nov 28, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a 15-PGDH activity adjusting function of a Dendropanax morbifera extract. More specifically, since it has been confirmed that the Dendropanax morbifera extract has an outstanding effect in suppressing 15-PGDH activity and so increasing PGE2, a composition of the present invention which contains the Dendropanax morbifera extract as an active ingredient has the advantage of being able to be used for producing a functional health food and a therapeutic agent for a disease associated with PGE2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.